Breaking News Instant updates and real-time market news.

NFLX

Netflix

$359.54

4.78 (1.35%)

13:36
04/18/19
04/18
13:36
04/18/19
13:36

NY Gov. Cuomo: Netflix planning $100M expansion in Manhattan, Brooklyn

New York Governor Andrew Cuomo announced that Netflix will expand its presence in New York with a production hub in New York City, bringing hundreds of jobs and up to $100M in investments to the city. The production hub will include an expanded office in Manhattan that will directly create 127 high-paying executive content, marketing and production development jobs over the next five years, and six sound stages in Brooklyn with the capacity to hold thousands of production crew jobs within five years, according to a statement. "Netflix is innovative, creative and bold - just like New Yorkers - and the expansion of this cutting-edge company in New York once again demonstrates the Empire State is open for business," Governor Cuomo said. "We're proud Netflix chose New York to grow its business, and we look forward to the jobs, economic activity and world-class productions this project will bring." Netflix's new corporate offices will take up approximately 100,000 square feet at 888 Broadway in Manhattan's Flatiron District. The offices will house the 127 new executive content acquisition, development, production, legal, publicity and marketing positions in addition to Netflix's 32 current New York-based employees. Reference Link

NFLX Netflix
$359.54

4.78 (1.35%)

04/17/19
MSCO
04/17/19
NO CHANGE
Target $450
MSCO
Overweight
Netflix 'pricing power on display' in Q1 report, guidance, says Morgan Stanley
Morgan Stanley analyst Benjamin Swinburne noted that Netflix reported stronger than expected Q1 subscriber growth in both the U.S. and internationally and that the company believes there has been no impact from its higher price increases on gross additions. Following the report, Swinburne raised his 2019 global paid net additions forecast to 30M from a prior 29M subscriber forecast and he continues to forecast steady EBIT margin expansion of 300 basis points annually and sees free cash flow turning positive in 2021. He keeps an Overweight rating and $450 price target on Netflix shares.
04/17/19
WEDB
04/17/19
NO CHANGE
Target $183
WEDB
Underperform
Netflix price target raised to $183 from $165 at Wedbush
Wedbush analyst Michael Pachter raised his price target for Netflix to $183 from $165 as Q1 results surpassed guidance and expectations. Nonetheless, the analyst expects content spending to trigger substantial cash burn for many years, while content migration and price hikes could cause a deceleration in subscriber growth, and consistently negative free cash flow makes DCF valuation impossible. Pachter reiterates an Underperform rating on the shares.
04/17/19
FBCO
04/17/19
NO CHANGE
Target $450
FBCO
Outperform
Netflix price target raised to $450 from $440 at Credit Suisse
Credit Suisse analyst Douglas Mitchelson raised his price target for Netflix (NFLX) to $450 from $440 due to the lower 15% terminal tax rate. Commenting on the company's quarterly results, the analyst notes that while not the net add beat many were hoping for, outlook commentary was "quite bullish," especially record first half of the year paid net additions in the face of record price increases, revenue growth accelerating the next few quarters, and a "very strong" second of the year content slate. Investor consternation will now shift from price increase churn to competition, but Disney+ (DIS) concerns are misplaced, he contends. Mitchelson reiterates an Outperform rating on Netflix's shares.
04/17/19
IMPC
04/17/19
NO CHANGE
Target $463
IMPC
Outperform
Netflix Q2 sub guidance, higher tax rate 'only flaws,' says Imperial Capital
Imperial Capital analyst David Miller says Netflix's Q1 results were ahead of guidance on "every relevant metric." The "only flaws" were U.S. subscriber guidance missing expectations and a higher effective tax rate for Q2, Miller tells investors in a post-earnings research note. The analyst maintains an Outperform rating on the shares with a $463 price target. However, he reduced his 2019 earnings estimates due to the expectation of higher effective taxes and 2020 earnings estimates due to higher spending and expenses. Nonetheless, Miller continues to see "multiple content-centric catalysts splayed throughout 2019." Netflix investors still have plenty to look forward to in terms of additional catalysts for subscriber growth throughout the year, he writes.

TODAY'S FREE FLY STORIES

THOR

Synthorx

$67.39

42.41 (169.78%)

11:00
12/09/19
12/09
11:00
12/09/19
11:00
Downgrade
Synthorx rating change  »

Synthorx downgraded to In…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BOLD

Audentes Therapeutics

$59.25

0.01 (0.02%)

10:59
12/09/19
12/09
10:59
12/09/19
10:59
Downgrade
Audentes Therapeutics rating change  »

Audentes Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ITCI

Intra-Cellular

$11.05

0.85 (8.33%)

10:55
12/09/19
12/09
10:55
12/09/19
10:55
Options
Intra Cellular Therapies put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Dec

CP

Canadian Pacific

$243.62

-1.86 (-0.76%)

10:52
12/09/19
12/09
10:52
12/09/19
10:52
Periodicals
Canadian Pacific crude train catches fire after derailing, Reuters reports »

A Canadian Pacific…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QRVO

Qorvo

$109.98

3.3 (3.09%)

, SWKS

Skyworks

$103.99

2.59 (2.55%)

10:50
12/09/19
12/09
10:50
12/09/19
10:50
On The Fly
Qorvo, Skyworks jump as BofA expresses optimism about 5G prospects »

Shares or Qorvo (QRVO)…

QRVO

Qorvo

$109.98

3.3 (3.09%)

SWKS

Skyworks

$103.99

2.59 (2.55%)

AAPL

Apple

$269.73

-0.95 (-0.35%)

MRVL

Marvell

$23.75

-0.43 (-1.78%)

ADI

Analog Devices

$114.78

-1.17 (-1.01%)

XLNX

Xilinx

$91.80

-0.07 (-0.08%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 06

    Jan

  • 28

    Jan

AMZN

Amazon.com

$1,759.42

8.63 (0.49%)

, MSFT

Microsoft

$151.80

0.03 (0.02%)

10:46
12/09/19
12/09
10:46
12/09/19
10:46
Periodicals
Amazon says Trump exerted 'improper pressure' in Pentagon contract, WSJ reports »

Amazon (AMZN) is claiming…

AMZN

Amazon.com

$1,759.42

8.63 (0.49%)

MSFT

Microsoft

$151.80

0.03 (0.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

CGC

Canopy Growth

$20.83

2.18 (11.69%)

10:45
12/09/19
12/09
10:45
12/09/19
10:45
Options
Canopy Growth call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:45
12/09/19
12/09
10:45
12/09/19
10:45
General news
FX Action: USD-JPY »

FX Action: USD-JPY was…

NOK

Nokia

$3.44

-0.04 (-1.15%)

, DDAIF

Daimler AG

$0.00

(0.00%)

10:44
12/09/19
12/09
10:44
12/09/19
10:44
Periodicals
Nokia pauses legal action against Daimler with mediation offer, Reuters reports »

Nokia (NOK) has…

NOK

Nokia

$3.44

-0.04 (-1.15%)

DDAIF

Daimler AG

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPPI

Spectrum

$9.83

(0.00%)

10:35
12/09/19
12/09
10:35
12/09/19
10:35
Options
Spectrum put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CTIC

CTI BioPharma

$0.95

(0.00%)

10:33
12/09/19
12/09
10:33
12/09/19
10:33
Hot Stocks
CTI BioPharma: PAC203 results show pactritinib 200mg 'well tolerated' »

CTI BioPharma announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:25
12/09/19
12/09
10:25
12/09/19
10:25
General news
Concerns over a year-end spike in the money markets »

Concerns over a year-end…

10:25
12/09/19
12/09
10:25
12/09/19
10:25
Conference/Events
JPMorgan Mexican strategist to hold an analyst/industry conference call »

Mexican Equity Strategist…

10:25
12/09/19
12/09
10:25
12/09/19
10:25
Conference/Events
UBS alternative energy windham to hold an analyst/industry conference call »

Alternative Energy &…

ZG

Zillow

$40.54

-0.18 (-0.44%)

, SPCE

Virgin Galactic

$8.20

0.92 (12.64%)

10:20
12/09/19
12/09
10:20
12/09/19
10:20
Initiation
Fly Intel: Top five analyst initiations »

Catch up on today's…

ZG

Zillow

$40.54

-0.18 (-0.44%)

SPCE

Virgin Galactic

$8.20

0.92 (12.64%)

PAA

Plains All American

$17.29

-0.01 (-0.06%)

PAGP

Plains GP Holdings

$17.37

0.01 (0.06%)

SSKN

Strata Skin Sciences

$2.20

0.04 (1.85%)

ZYME

Zymeworks

$41.25

-0.45 (-1.08%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

  • 11

    Dec

  • 30

    Dec

  • 04

    Feb

MMM

3M

$169.82

-1.675 (-0.98%)

, PNC

PNC Financial

$153.68

-0.13 (-0.08%)

10:20
12/09/19
12/09
10:20
12/09/19
10:20
Downgrade
Fly Intel: Top five analyst downgrades »

Catch up on today's…

MMM

3M

$169.82

-1.675 (-0.98%)

PNC

PNC Financial

$153.68

-0.13 (-0.08%)

M

Macy's

$14.96

-0.19 (-1.25%)

CVX

Chevron

$117.18

-0.8 (-0.68%)

HBIO

Harvard Bioscience

$2.83

-0.12 (-4.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

  • 15

    Jan

QRVO

Qorvo

$109.72

3.04 (2.85%)

, SWKS

Skyworks

$104.55

3.15 (3.11%)

10:20
12/09/19
12/09
10:20
12/09/19
10:20
Upgrade
Fly Intel: Top five analyst upgrades »

Catch up on today's…

QRVO

Qorvo

$109.72

3.04 (2.85%)

SWKS

Skyworks

$104.55

3.15 (3.11%)

FATE

Fate Therapeutics

$19.69

6.05 (44.35%)

WING

Wingstop

$84.26

4.04 (5.04%)

HUN

Huntsman

$23.31

0.48 (2.10%)

FTV

Fortive

$74.68

1.82 (2.50%)

DOW

Dow Inc.

$53.29

0.04 (0.08%)

KRA

Kraton

$23.96

0.92 (3.99%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 12

    Dec

  • 13

    Dec

  • 18

    Dec

  • 19

    Dec

TPR

Tapestry

$25.85

0.305 (1.19%)

10:20
12/09/19
12/09
10:20
12/09/19
10:20
Options
Upside February calls see heavy trading in Tapestry »

Upside February calls see…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SWTX

SpringsWorks Therapeutics

$28.00

3.01 (12.04%)

, GSK

GlaxoSmithKline

$45.64

0.13 (0.29%)

10:19
12/09/19
12/09
10:19
12/09/19
10:19
Hot Stocks
SpringsWorks reports Glaxo presentation of preclinical data on nirogacestat »

SpringWorks Therapeutics…

SWTX

SpringsWorks Therapeutics

$28.00

3.01 (12.04%)

GSK

GlaxoSmithKline

$45.64

0.13 (0.29%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

10:17
12/09/19
12/09
10:17
12/09/19
10:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AGIO

Agios Pharmaceuticals

$44.49

3.56 (8.70%)

10:16
12/09/19
12/09
10:16
12/09/19
10:16
Hot Stocks
Agios Pharmaceuticals reports new data from DRIVE PK Phase 2 study »

Agios Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 13

    Dec

$NYE

NYSE Market Internals

$0.00

(0.00%)

10:16
12/09/19
12/09
10:16
12/09/19
10:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FTSV

Forty Seven

$22.25

7.85 (54.51%)

10:15
12/09/19
12/09
10:15
12/09/19
10:15
Hot Stocks
Forty Seven announces preclinical proof-of-concept data for FSI-174 »

Forty Seven announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 09

    Dec

NKTR

Nektar

$22.00

1.55 (7.58%)

10:15
12/09/19
12/09
10:15
12/09/19
10:15
Hot Stocks
Nektar announces presentation of data for NKTR-255 at ASH »

Nektar Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

UPS

UPS

$116.87

-0.67 (-0.57%)

10:15
12/09/19
12/09
10:15
12/09/19
10:15
Hot Stocks
UPS reports expansion of UPS Worldwide Express, Express Plus across 40 countries »

UPS announced an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.